This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2 MF Holick (2003) Vitamin D: a millennium perspective. J Cell Biochem 88, 296–307.
4 GM Bull & J Morton (1975) Seasonal and short-term relationships of temperature with deaths from myocardial and cerebral infarction. Age Ageing 4, 19–31.
5 R Scragg (1981) Seasonality of cardiovascular disease mortality and the possible protective effect of ultraviolet radiation. Int J Epidemiol 10, 337–341.
6 DS Grimes , E Hindle & T Dyer (1996) Sunlight, cholesterol and coronary heart disease. QJM 89, 579–589.
7 SG Rostand (1997) Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 30, 150–156.
9 B Caballero (2007) The global epidemic of obesity: an overview. Epidemiol Rev 29, 1–5.
10 GA Bray & T Bellanger (2006) Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 29, 109–117.
11 C Sarti & J Gallagher (2006) The metabolic syndrome: prevalence, CHD risk, and treatment. J Diabetes Complications 20, 121–132.
12 SJ Parikh , M Edelman , GI Uwaifo , et al. (2004) The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 89, 1196–1199.
13 PW Wilson , WB Kannel , H Silbershatz , et al. (1999) Clustering of metabolic factors and coronary heart disease. Arch Intern Med 159, 1104–1109.
14 R Krause , M Buhring , W Hopfenmuller , et al. (1998) Ultraviolet B and blood pressure. Lancet 352, 709–710.
15 J Merke , W Hofmann , D Goldschmidt , et al. (1987) Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int 41, 112–114.
16 J Merke , P Milde , S Lewicka , et al. (1989) Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3: studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 83, 1903–1915.
17 R Scragg , M Sowers & C Bell (2007) Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 20, 713–719.
18 R Jorde , Y Figenschau , N Emaus , et al. (2010) Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension 55, 792–798.
19 MF Holick (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81, 353–373.
20 YC Li , J Kong , M Wei , et al. (2002) 1,25-Dihydroxyvitamin D (3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110, 229–238.
21 SG Rostand & TB Drueke (1999) Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56, 383–392.
22 PN Sambrook , JS Chen , LM March , et al. (2004) Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin D status, bone mass and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab 89, 5477–5481.
23 S Hashemipour , B Larijani , H Adibi , et al. (2004) Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health 4, 38–44.
27 CL Craig , AL Marshall , M Sjostrom , et al. (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35, 1381–1395.
28 FH Esfahani , G Asghari , P Mirmiran , et al. (2010) Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study. J Epidemiol 20, 150–158.
32 DX Tishkoff , KA Nibbelink , KH Holmberg , et al. (2008) Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology 149, 558–564.
33 E Giovannucci , Y Liu , BW Hollis , et al. (2008) 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168, 1174–1180.
34 H Dobnig , S Pilz , H Scharnagl , et al. (2008) Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 168, 1340–1349.
35 TJ Wang , MJ Pencina , SL Booth , et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117, 503–511.
36 MB Snijder , P Lips , JC Seidell , et al. (2007) Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med 261, 558–565.
37 A Zittermann , S Frisch , HK Berthold , et al. (2009) Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89, 1321–1327.
39 M Pfeifer , B Begerow , HW Minne , et al. (2001) Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 86, 1633–1637.
40 KD Schluter & H Piper (1998) Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res 37, 34–41.
42 D Somjen , Y Weisman , F Kohen , et al. (2005) 25-Hydroxyvitamin D3-1α-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 111, 1666–1671.
44 V Perkovic , TD Hewitson , KJ Kelynack , et al. (2003) Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells. Kidney Blood Press Res 26, 27–33.
45 P Andersson , E Rydberg & R Willenheimer (2004) Primary hyperparathyroidism and heart disease – a review. Eur Heart J 25, 1776–1787.
46 N Garcia de la Torre , JA Wass & HE Turner (2003) Parathyroid adenomas and cardiovascular risk. Endocr Relat Cancer 10, 309–322.
47 JL Martin-Ventura , M Ortego , P Esbrit , et al. (2003) Possible role of parathyroid hormone-related protein as a proinflammatory cytokine in atherosclerosis. Stroke 34, 1783–1789.
48 RN Foley , PS Parfrey & MJ Sarnaak (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32, 5 Suppl. 3, S112–S119.
49 P Khajehdehi & S Taheri (2003) Effect of oral calcitriol pulse therapy on the lipid, calcium, and glucose homeostasis of hemodialysis patients: its safety in a combination with oral calcium carbonate. J Ren Nutr 13, 78–83.
53 MJ Barger-Lux , RP Heaney , SJ Lanspa , et al. (1995) An investigation of sources of variation in calcium absorption efficiency. J Clin Endocrinol Metab 80, 406–411.
55 IR Reid (2004) Effects of calcium supplementation on circulating lipids: potential pharmacoeconomic implications. Drugs Aging 21, 7–17.
58 S Malik (2003) Transcriptional regulation of the apolipoprotein AI gene. Front Biosci 8, d360–d368.
59 J Auwerx , R Bouillon & H Kesteloot (1992) Relation between 25-hydroxyvitamin D3, apolipoprotein A-1 and high density lipoprotein cholesterol. Aterioscler Thromb 12, 671–674.
60 K Wehmeier , A Beers , MJ Haas , et al. (2005) Inhibition of apolipoprotein AI gene expression by 1,25-dihydroxyvitamin D3. Biochim Biophys Acta 1737, 16–26.